Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Genetics of multidrug resistance.
J M Croop, … , P Gros, D E Housman
J M Croop, … , P Gros, D E Housman
Published May 1, 1988
Citation Information: J Clin Invest. 1988;81(5):1303-1309. https://doi.org/10.1172/JCI113455.
View: Text | PDF
Research Article Article has an altmetric score of 3

Genetics of multidrug resistance.

  • Text
  • PDF
Abstract

Authors

J M Croop, P Gros, D E Housman

×

Total citations by year

Year: 2012 2011 2009 2005 2003 2001 2000 1999 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Total
Citations: 1 1 4 1 1 2 1 1 1 7 5 12 12 5 9 11 4 1 79
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (79)

Title and authors Publication Year
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Relationship between expression of Pad1 homologue and multidrug resistance of idiopathic nephrotic syndrome
Z Ma, X Gao, W Zhao, Y Li, C Li, C Li
Pediatrics International 2009
Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance
M Vigodner, JH Weisburg, V Shrivastava, RA Marmor, J Fathy, N Skop
Cell and Tissue Research 2009
Principles of Cancer Biotherapy
RK Oldham, RO Dillman
2009
Progress in Botany
K Esser, U Lüttge, W Beyschlag, J Murata
2005
Double-Phase Tc-99m MIBI Scintigraphy as a Therapeutic Predictor in Patients with Non-Hodgkin’s Lymphoma
HC Song, JJ Lee, HS Bom, IJ Chung, HJ Kim, YK Park, EE Kim
Clinical Nuclear Medicine 2003
Liposomal cancer chemotherapy: current clinical applications and future prospects
KJ Harrington
Expert Opinion on Investigational Drugs 2001
99mTc-MIBI SPECT in small cell lung cancer patients before chemotherapy and after unresponsive chemotherapy
Y Yamamoto, Y Nishiyama, K Fukunaga, K Satoh, J Fujita, M Ohkawa
Annals of Nuclear Medicine 2001
P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia
U Tidefelt, J Liliemark, A Gruber, E Liliemark, B Sundman-Engberg, G Juliusson, L Stenke, A Elmhorn-Rosenborg, L Möllgård, S Lehman, D Xu, A Covelli, B Gustavsson, C Paul
Journal of Clinical Oncology 2000
Nuclear Oncology
C Aktolun, WN Tauxe
Nuclear Oncology 1999
Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis
LF Verdonck, HG van Heugten
Leukemia Research 1997
Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids
M Silva, P Kantharidis, DM Wall, L Campbell, V Vrazas, G Nadalin, SJ Kaczmarczyk, XF Hu, JD Parkin, JR Zalcberg
British Journal of Cancer 1996
Tobacco budworm P-glycoprotein: biochemical characterization and its involvement in pesticide resistance
CL Lanning, RL Fine, JJ Corcoran, HM Ayad, RL Rose, MB Abou-Donia
Biochimica et Biophysica Acta (BBA) - General Subjects 1996
Multidrug resistance-associated protein expression in clinical gastric carcinoma
K Endo, Y Maehara, Y Ichiyoshi, T Kusumoto, Y Sakaguchi, S Ohno, K Sugimachi
Cancer 1996
Conferring drug resistance by MDR1 gene transfection increases susceptibility to irradiation and lipid peroxidation in 3T3 cell line
R Mazzanti, O Fantappie, P Fabrizio, S Pacini, P Relli, F Casamassima, F Milano, M Ruggiero
Free radical biology & medicine 1996
P-glycoprotein multidrug resistance and cancer
I Bosch, J Croop
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1996
MDR1 gene expression in solid tumours
LJ Goldstein
European Journal of Cancer 1996
Expression of Drosophila melanogaster P-glycoproteins is associated with ATP channel activity
I Bosch, GR Jackson, JM Croop, HF Cantiello
American journal of physiology. Cell physiology 1996
Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment
R Radinsky
Cancer and Metastasis Reviews 1995
A P-glycoprotein protects Caenorhabditis elegans against natural toxins
A Broeks, HW Janssen, J Calafat, RH Plasterk
The EMBO Journal 1995
8Modulation of multidrug resistance in multiple myeloma
P Sonneveld
Baillière's Clinical Haematology 1995
MDR-1 Expression in Non-Hodgkin's Lymphomas is Unrelated to Treatment Intensity or Response to Therapy
MC Finnegan, J Royds, JR Goepel, P Lorigan, BW Hancock, MH Goyns
Leukemia & Lymphoma 1995
P-glycoprotein in Adult Solid Tumors: Expression and Prognostic Significance
JC Leighton, LJ Goldstein
Hematology/Oncology Clinics of North America 1995
A mathematical model for the inhibition of the multidrug resistance-associated P-glycoprotein pump
S Michelson, D Slate
Bulletin of Mathematical Biology 1994
XIIXVI. Yeast sequencing reports. Mapping and sequencing of two yeast genes belonging to the ATP-binding cassette superfamily
M Dean, R Allikmets, B Gerrard, C Stewart, A Kistler, B Shafer, S Michaelis, J Strathern
Yeast 1994
Two Multidrug-Resistant Friend Leukemic Cell Lines Selected with Different Drugs Exhibit Overproduction of Different P-Glycoproteins
N Savaraj, TJ Lampidis, JY Zhao, CJ Wu, LD Teeter, MT Kuo
Cancer Investigation 1994
P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells
M Cianfriglia, MC Willingham, M Tombesi, GV Scagliotti, G Frasca, A Chersi
International Journal of Cancer 1994
Hepatic vectorial transport of xenobiotics
GA LeBlanc
Chemico-Biological Interactions 1994
Multiple drug resistance in the pathogenic protozoa
P Upcroft
Acta Tropica 1994
Biochemical and Molecular Aspects of Selected Cancers
E Eigenbrodt, U Gerbracht, S Mazurek, P Presek, R Friis
Biochemical and Molecular Aspects of Selected Cancers 1994
Molecular basis of Ph+ leukemia and finding the way to treat them
GD Telegeev, MV Dybkov, OI Karpenko, HI Cherepenko
Biopolymers and Cell 1994
Modulation of P-Glycoprotein by Protein Kinase C.alpha. in a Baculovirus Expression System
S Ahmad, AR Safa, RI Glazer
Biochemistry 1994
Multiple Drug Resistance in Cancer
M Clynes
1994
Transcriptional regulation of multidrug resistance in breast cancer
RI Glazer, C Rohlff
Breast Cancer Research and Treatment 1994
Modulation of tumor cell response to chemotherapy by the organ environment
IJ Fidler, C Wilmanns, A Staroselsky, R Radinsky, Z Dong, D Fan
Cancer and Metastasis Reviews 1994
High levels of P-glycoprotein detected in isolated brain capillaries
L Jetté, B Têtu, R Béliveau
Biochimica et Biophysica Acta (BBA) - Biomembranes 1993
P-glycoprotein structure and evolutionary homologies
JM Croop
Cytotechnology 1993
Current status and future directions of research on multidrug resistance
GH Mickisch
Urological Research 1993
Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin
MN BENCHEKROUN, P POURQUIER, B SCHOTT, J ROBERT
European Journal of Biochemistry 1993
Cloning and organization of the abc and mdl genes of Escherichia coli: relationship to eukaryotic multidrug resistance
R Allikmets, B Gerrard, D Court, M Dean
Gene 1993
Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines
XK Li, H Kobayashi, JF Holland, T Ohnuma
Leukemia Research 1993
Cleavage of human MDR1 mRNA by a hammerhead ribozyme
H Kobayashi, T Dorai, JF Holland, T Ohnuma
FEBS Letters 1993
Mathematical models for multidrug resistance and its reversal
S Michelson
Cytotechnology 1993
Human cell lines as models for multidrug resistance in solid tumours
M Clynes, M Heenan, K Hall
Cytotechnology 1993
Frontiers in Cerebral Vascular Biology
LR Drewes, AL Betz
1993
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein
AH Schinkel, S Kemp, M Dollé, G Rudenko, E Wagenaar
The Journal of biological chemistry 1993
Current status and future directions of research on multidrug resistance: The impact of contemporary biotechnology
GH Mickisch
Urological Research 1993
A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance
S Michelson, D Slate
Bulletin of Mathematical Biology 1992
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia
M Michieli, D Damiani, A Geromin, A Michelutti, R Fanin, D Raspadorl, D Russo, G Visani, A Dinota, S Pileri, T Tsuruo, M Grandi, M Baccaranl, S Tura
European Journal of Haematology 1992
Multidrug resistance in human cancer
LJ Goldstein, I Pastan, MM Gottesman
Critical Reviews in Oncology/Hematology 1992
ATP and GTP as alternative energy sources for vinblastine transport by P-170 in KB-V1 plasma membrane vesicles
IH Lelong, R Padmanabhan, E Lovelace, I Pastan, MM Gottesman
FEBS Letters 1992
Mechanisms of Lymphocyte Activation and Immune Regulation IV
S Gupta, TA Waldmann
1992
Isolation and characterization of Drosophila multidrug resistance gene homologs
CT Wu, M Budding, MS Griffin, JM Croop
Molecular and cellular biology 1991
Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissues
R Kim, N Hirabayashi, M Nishiyama, K Aogi, T Toge
The Japanese Journal of Surgery 1991
Modulation of drug resistance in homoharringtonine-resistant C-1300 neuroblastoma cells with cyclosporine A and dipyridamole
CK Tebbi, D Chervinsky, RM Baker
Journal of Cellular Physiology 1991
Keynote address: Multidrug resistance: A pleiotropic response to cytotoxic drugs
CR Fairchild, KH Cowan
International journal of radiation oncology, biology, physics 1991
Molecular and Clinical Advances in Anticancer Drug Resistance
RF Ozols
1991
Newly formed chromosome-like structures in independent mouse P388 sublines with developed in vivomdr1 gene amplification
NS Demidova, OB Chernova, EY Siyanova, AS Goncharova, BP Kopnin
Somatic Cell and Molecular Genetics 1991
Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells
IB Roninson
1991
Detoxification Mechanisms and Tumor Cell Resistance to Anticancer Drugs
S Kuzmich, KD Tew
Medicinal Research Reviews 1991
Structure of the human MDR3 gene and physical mapping of the human MDR locus
CR Lincke, JJ Smit, T van der Velde-Koerts, P Borst
The Journal of biological chemistry 1991
Acute lymphoblastic leukemia in children: An update of clinical, biological, and therapeutic aspects
DR Miller, LP Miller
Critical Reviews in Oncology/Hematology 1990
Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells
F Borellini, A Aquino, SF Josephs, RI Glazer
Molecular and cellular biology 1990
Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas
LD Teeter, FF Becker, FV Chisari, DJ Li, MT Kuo
Molecular and cellular biology 1990
Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells
J Michaeli, YB Lebedev, VM Richon, ZX Chen, PA Marks, RA Rifkind
Molecular and cellular biology 1990
Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells
M Raymond, E Rose, DE Housman, P Gros
Molecular and cellular biology 1990
Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus
RJ Arceci, F Baas, R Raponi, SB Horwitz, D Housman, JM Croop
Molecular Reproduction and Development 1990
P-glycoproteins in pathology: The multidrug resistance gene family in humans
RS Weinstein, JR Kuszak, LF Kluskens, JS Coon
Human Pathology 1990
Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance
R Pincus, ID Goldman
Biochemical Pharmacology 1990
A system for Monte Carlo simulation of heterogeneous tumor cell populations
S Michelson
Computers & Mathematics with Applications 1990
Progress in Inorganic Chemistry: Bioinorganic Chemistry
SJ Lippard
1990
Genetic basis of multidrug resistance of tumor cells
SE Kane, I Pastan, MM Gottesman
Journal of Bioenergetics and Biomembranes 1990
Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance
M Azzaria, E Schurr, P Gros
Molecular and cellular biology 1989
Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene
M Raymond, P Gros
Proceedings of the National Academy of Sciences 1989
Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method
M Volm, T Efferth, M Bak, AD Ho, J Mattern
European Journal of Cancer and Clinical Oncology 1989
Identification of P-glycoprotein in renal brush border membranes
DM Lieberman, RA Reithmeier, V Ling, JH Charuk, H Goldberg, KL Skorecki
Biochemical and Biophysical Research Communications 1989
The multidrug transporter, a double-edged sword
MM Gottesman, I Pastan
The Journal of biological chemistry 1988

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
14 readers on Mendeley
See more details